In melanoma cells, SIRT1 silences MXD dimerization protein 1 (Mxd1) by binding to DNMT3B, thereby increasing resistance to dead-cancer-induced stress, which leads to increased Myc activity and drives melanoma progression 177. Here, MYC is linked to cancer.